Background In acute coronary syndrome(ACS),mental disorder is associated with poorer clinical outcomes,but there are still few data.Methods This study consecutively enrolled ACS patients with anxiety/depression at our...Background In acute coronary syndrome(ACS),mental disorder is associated with poorer clinical outcomes,but there are still few data.Methods This study consecutively enrolled ACS patients with anxiety/depression at our center from January 2018 to July 2020.Patients were divided into a control group(n=271)and an experiment group(n=361)based on whether they underwent psychotherapy.Patients were followed up at 12 months.The primary endpoint event was adverse cardiovascular events(MACE),including death,myocardial infarction,re-angina and the target vessel revascularization.Results There were no statistical differences in admission Hamilton anxiety scale(HAMA)and Hamilton depression scale(HAMD)between the two groups.The HAMA score(9.18±2.2vs.21.26±3.9;P<0.001)and HAMD score(23.15±3.8 vs.13.28±2.7;P<0.001)were lower in the experimental group than in the control group at discharge.Multiple logistic regression analysis showed that psychological status at discharge[OR 0.20,95%CI(0.011-0.421),P=0.020]and treatment for psychological disorders[OR 0.2095%CI(0.011-0.421),P=0.020]were independent predictors of 1-year MACE.Conclusions Anxiety and depressive status at discharge were independent associated with adverse events.psychotherapy significantly reduced MACEs in ACS,particularly recurrent angina,but not myocardial infarction,revascularization or all-cause mortality.展开更多
Background It was controversial that deferred stenting strategy could reduce no-reflow phenomena or major adverse cardiovascular events(MACEs)in primary percutaneous coronary intervention(PCI)for patients with STsegme...Background It was controversial that deferred stenting strategy could reduce no-reflow phenomena or major adverse cardiovascular events(MACEs)in primary percutaneous coronary intervention(PCI)for patients with STsegment elevation myocardial infarction(STEMI).Methods A total of 513 STEMI patients with high thrombus burden were retrospectively enrolled from January 2015 to January 2020.These patients were divided into two groups:experimental(with deferred stent implantation strategy,n=118)and control group(with immediate stenting strategy,n=395).The primary endpoint of this study was the incidence of no-reflow events.The secondly endpoints the in-hospital MACEs and one-year follow-up.Results The baseline characteristics were compared between the two groups.The occurrence of no-reflow phenomenon was significantly lower in the experiment group than the control group(16.9%vs.23.8%,P=0.035),which was mainly driven by the slow-flow(13.5%in experiment group vs.17.2%in control group,P=0.041).No significant difference was found between two groups in terms of in-hospital adverse events.The experiment group was associated with lower MACE rate than the control group(8.5%vs.15.7%,P=0.013)at one-year follow-up.Conclusions Deferred stenting had potential effect to reduce the risk no-reflow phenomenon in STEMI patients with high thrombus burden.This method was relatively safe and was associated with better clinical outcome.展开更多
基金supported by Dongguan City Social Science and Technology Development(General)Project(No.202050715059412)
文摘Background In acute coronary syndrome(ACS),mental disorder is associated with poorer clinical outcomes,but there are still few data.Methods This study consecutively enrolled ACS patients with anxiety/depression at our center from January 2018 to July 2020.Patients were divided into a control group(n=271)and an experiment group(n=361)based on whether they underwent psychotherapy.Patients were followed up at 12 months.The primary endpoint event was adverse cardiovascular events(MACE),including death,myocardial infarction,re-angina and the target vessel revascularization.Results There were no statistical differences in admission Hamilton anxiety scale(HAMA)and Hamilton depression scale(HAMD)between the two groups.The HAMA score(9.18±2.2vs.21.26±3.9;P<0.001)and HAMD score(23.15±3.8 vs.13.28±2.7;P<0.001)were lower in the experimental group than in the control group at discharge.Multiple logistic regression analysis showed that psychological status at discharge[OR 0.20,95%CI(0.011-0.421),P=0.020]and treatment for psychological disorders[OR 0.2095%CI(0.011-0.421),P=0.020]were independent predictors of 1-year MACE.Conclusions Anxiety and depressive status at discharge were independent associated with adverse events.psychotherapy significantly reduced MACEs in ACS,particularly recurrent angina,but not myocardial infarction,revascularization or all-cause mortality.
文摘Background It was controversial that deferred stenting strategy could reduce no-reflow phenomena or major adverse cardiovascular events(MACEs)in primary percutaneous coronary intervention(PCI)for patients with STsegment elevation myocardial infarction(STEMI).Methods A total of 513 STEMI patients with high thrombus burden were retrospectively enrolled from January 2015 to January 2020.These patients were divided into two groups:experimental(with deferred stent implantation strategy,n=118)and control group(with immediate stenting strategy,n=395).The primary endpoint of this study was the incidence of no-reflow events.The secondly endpoints the in-hospital MACEs and one-year follow-up.Results The baseline characteristics were compared between the two groups.The occurrence of no-reflow phenomenon was significantly lower in the experiment group than the control group(16.9%vs.23.8%,P=0.035),which was mainly driven by the slow-flow(13.5%in experiment group vs.17.2%in control group,P=0.041).No significant difference was found between two groups in terms of in-hospital adverse events.The experiment group was associated with lower MACE rate than the control group(8.5%vs.15.7%,P=0.013)at one-year follow-up.Conclusions Deferred stenting had potential effect to reduce the risk no-reflow phenomenon in STEMI patients with high thrombus burden.This method was relatively safe and was associated with better clinical outcome.